Literature DB >> 11565606

Alterations in immune cell phenotype and function after experimental spinal cord injury.

P G Popovich1, S Stuckman, I E Gienapp, C C Whitacre.   

Abstract

Traumatic injury to the spinal cord initiates a cascade of inflammatory-mediated injury and repair processes within the nervous system. In parallel, spinal injury could influence peripheral mechanisms of host defense (e.g., wound healing, antibody production) by altering lymphocyte phenotype and function. The goal of this study was to evaluate the physiological impact of spinal contusion injury on phenotypic and functional indices of lymphocyte activation. A flow cytometric time-course analysis of lymphocytes isolated from lymph node and spleen revealed an increase in CD4+ and a decrease in CD8+ lymphocytes during the first week post injury. The functional potential of lymphocytes was also evaluated based on their ability to proliferate in the presence of a biologically relevant antigen (myelin basic protein, MBP) or a lymphocyte mitogen. The data revealed increased proliferation to MBP by 3 days postinjury in lymphocytes isolated from lymph node but not spleen. By 1 week postinjury, increased proliferation to mitogen was noted in both the lymph node and the spleen suggesting a general increase in lymphocyte reactivity during this time interval. Circulating corticosterone (CORT), an endogenous glucocorticoid with significant effects on lymphocyte phenotype and function, was elevated within 24 h after spinal cord injury (SCI) and remained above control levels throughout the duration of our studies (up to 1 month postinjury). The present data suggest injury-associated changes in immune cell phenotype and function paralleled by the activation of the hypothalamic-pituitary-adrenal (HPA) axis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565606     DOI: 10.1089/089771501750451866

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  23 in total

1.  Assessment of depression in a rodent model of spinal cord injury.

Authors:  Kelsey Luedtke; Sioui Maldonado Bouchard; Sarah A Woller; Mary Katherine Funk; Miriam Aceves; Michelle A Hook
Journal:  J Neurotrauma       Date:  2014-05-08       Impact factor: 5.269

2.  Characterization of the Antibody Response after Cervical Spinal Cord Injury.

Authors:  Antigona Ulndreaj; Apostolia Tzekou; Andrea J Mothe; Ahad M Siddiqui; Rachel Dragas; Charles H Tator; Emina E Torlakovic; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2016-12-21       Impact factor: 5.269

3.  Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy.

Authors:  T Bucky Jones; D Michele Basso; Ajeet Sodhi; Jonathan Z Pan; Ronald P Hart; Robert C MacCallum; Sunhee Lee; Caroline C Whitacre; Phillip G Popovich
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

4.  Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury.

Authors:  Ryan D Fortune; Raymond J Grill; Christine Beeton; Mark Tanner; Redwan Huq; David S Loose
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

Review 5.  Spinal cord injury, immunodepression, and antigenic challenge.

Authors:  Katherine S Held; Thomas E Lane
Journal:  Semin Immunol       Date:  2014-04-18       Impact factor: 11.130

6.  Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation.

Authors:  Kurt M Lucin; Virginia M Sanders; T Bucky Jones; William B Malarkey; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-02       Impact factor: 5.330

7.  Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis.

Authors:  Pia Kivisäkk; Jaime Imitola; Stine Rasmussen; Wassim Elyaman; Bing Zhu; Richard M Ransohoff; Samia J Khoury
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

8.  B-cell maturation antigen, a proliferation-inducing ligand, and B-cell activating factor are candidate mediators of spinal cord injury-induced autoimmunity.

Authors:  Jonah W Saltzman; Ricardo A Battaglino; Loise Salles; Prateek Jha; Supreetha Sudhakar; Eric Garshick; Helen L Stott; Ross Zafonte; Leslie R Morse
Journal:  J Neurotrauma       Date:  2013-03-28       Impact factor: 5.269

9.  Inflammation and Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes.

Authors:  Alpa Trivedi; Andrea D Olivas; Linda J Noble-Haeusslein
Journal:  Clin Neurosci Res       Date:  2006-12

10.  Spinal Cord Injury Leads to Hippocampal Glial Alterations and Neural Stem Cell Inactivation.

Authors:  Ignacio Jure; Alejandro F De Nicola; Juan Manuel Encinas; Florencia Labombarda
Journal:  Cell Mol Neurobiol       Date:  2020-06-14       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.